Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Induction of inducible nitric oxide synthase by Epstein-Barr virus B95-8-derived LMP1 in Balb/3T3 cells promotes stress-induced cell death and impairs LMP1-mediated transformation

Abstract

The latent membrane protein 1 (LMP1) of Epstein-Barr virus (EBV) causes cellular transformation and activation of several intracellular signaling events. In this report, we show that BLMP1 (encoded by the LMP1 gene derived from the B95-8 strain of EBV) triggers the expression of inducible nitric oxide synthase (iNOS) in Balb/3T3 fibroblasts. Intriguingly, NLMP1, a natural sequence variant of LMP1 identified in EBV-positive nasopharyngeal carcinoma biopsy, does not similarly induce iNOS expression. BLMP1-induced iNOS in Balb/3T3 cells is active to produce nitric oxide (NO), and NO production can be blocked by several iNOS inhibitors. When subjected to environmental stress, Balb/3T3 cells that produce NO lose viability more rapidly than non NO-producing cells. Blockage of NO generation by iNOS inhibitors enhances the viability of NO-producing cells under stress conditions. The activities of caspase-3 and c-Jun N-terminal kinase, two important regulators mediating stress-induced apoptosis, are significantly potentiated following heat shock treatment of BLMP1-expressing/NO-producing cells, compared to parental and NLMP1-expressing cells. Furthermore, treatment with iNOS inhibitor augmented the cloning efficiency (in culture) and tumor growth (in nude mice) of BLMP1-expressing/NO-producing cells. Collectively, the results demonstrate that BLMP1 induces iNOS expression and NO production in Balb/3T3 cells, which leads to the alteration of cell functions, including sensitivity to environmental stress, capability to colonize independent of anchorage and tumorigenicity in nude mice. Our data additionally implicate that the differential iNOS induction potential of the two LMP1 forms may represent the basis of a functional difference between the two LMP1 proteins.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8

Similar content being viewed by others

References

  • Aaltoma SH, Lipponen PK, Kosma VM . 2001 Anticancer Res. 21: 3101–3106

  • Ambs S, Merriam WG, Bennett WP, Felley-Bosco E, Ogunfusika MO, Oser SM, Klein S, Shields PG, Billiar TR, Harris CC . 1998a Cancer Res. 58: 334–341

  • Ambs S, Merriam WG, Ogunfusika MO, Bennett WP, Ishibe N, Hussain SP, Tzeng E, Geller DA, Billiar TR, Harris CC . 1998b Nat. Med. 4: 1371–1376

  • Arvanitakis L, Yaseen N, Sharma S . 1995 J. Immunol. 155: 1047–1056

  • Asano K, Chee CB, Gaston B, Lilly CM, Gerard C, Drazen JM, Stamler JS . 1994 Proc. Natl. Acad. Sci. USA 91: 10089–10093

  • Baichwal VR, Sugden B . 1988 Oncogene 2: 461–467

  • Birkenbach M, Liebowitz D, Wang F, Sample J, Kieff E . 1989 J. Virol. 63: 4079–4084

  • Bredt DS, Hwang PM, Glatt CE, Lowenstein C, Reed RR, Snyder SH . 1990 Nature 347: 768–770

  • Campbell IL . 1996 J. Neuroimmunol. 71: 31–36

  • Chan WH, Yu JS, Yang SD . 1998 J. Protein Chem. 17: 485–494

  • Chan WH, Yu JS, Yang SD . 2000 Biochem. J. 351: 221–232

  • Chen ML, Tsai CN, Liang CL, Shu CH, Huang CR, Sulizeanu D, Liu ST, Chang YS . 1992 Oncogene 7: 2131–2140

  • Chen YR, Wang X, Templeton D, Davis RJ, Tan TH . 1996 J. Biol. Chem. 271: 31929–31936

  • Cobbs CS, Brenman JE, Aldape KD, Bredt DS, Isreal MA . 1995 Cancer Res. 55: 727–730

  • Dawson CW, Eliopoulos AG, Blake SM, Barker R, Young LS . 2000 Virology 272: 204–217

  • Dawson CW, Rickinson AB, Young LS . 1990 Nature 344: 777–780

  • Derijard B, Hibi M, Wu IH, Barrett T, Su B, Deng T, Karin M, Davis RJ . 1994 Cell 76: 1025–1037

  • Devergne O, Hatzivassiliou E, Izumi KM, Kaye KM, Kleijnen MF, Kieff E, Mosialos G . 1996 Mol. Cell. Biol. 16: 7098–7108

  • Dimmeler S, Zeiher AM . 1997 Nitric Oxide 1: 275–281

  • Eliopoulos AG, Rickinson AB . 1998 Curr. Biol. 8: R196–R198

  • Eliopoulos AG, Young LS . 1998 Oncogene 16: 1731–1742

  • Esptein MA, Achong BG, Barr YM . 1964 Lancet 1: 702–703

  • Fahraeus R, Fu HL, Ernberg I, Finke J, Rowe M, Klein G, Falk K, Nillson E, Yadav M, Busson P, Tursz T, Kallin B . 1988 Int. J. Cancer 42: 329–338

  • Fahraeus R, Rymo L, Rhim JS, Klein G . 1990 Nature 345: 447–449

  • Fairbairn LJ, Stewart JP, Hampson IN, Arrand JR, Dexter TM . 1993 J. Gen. Virol. 74: 247–254

  • Fielding CA, Sandvej K, Mehl A, Brennan P, Jones M, Rowe M . 2001 J. Virol. 75: 9129–9141

  • Frisch SM, Ruoslahti E . 1997 Curr. Opin. Cell Biol. 9: 701–706

  • Gao X, Tajima M, Sairenji T . 1999 Virology 258: 375–381

  • Gires O, Zimber-Strobl U, Gonnella R, Ueffing M, Marschall G, Zeidler R, Pich D, Hammerschmidt W . 1997 EMBO J. 16: 6131–6140

  • Hammerschmidt W, Sugden B, Baichwal VR . 1989 J. Virol. 63: 2469–2475

  • Hanto DW, Frizzera G, Gajl-Peczalska KJ, Balfour HH, Simmons RL, Najarian JS . 1985 Transplant Proc. 17: 89–92

  • Henderson S, Rowe M, Gregory C, Croom-Carter D, Wang F, Longnecker R, Kieff E, Rickinson A . 1991 Cell 65: 1107–1115

  • Henle G, Henle W, Diehl V . 1968 Proc. Natl. Acad. Sci. USA 59: 94–101

  • Hu LF, Zabarovsky ER, Chen F, Cao SL, Ernberg I, Klein G, Winberg G . 1991 J. Gen. Virol. 72: 2399–2409

  • Hu LF, Chen F, Zheng X, Ernberg I, Cao SL, Christensson B, Klein G, Winberg G . 1993 Oncogene 8: 1575–1583

  • Iwasaki Y, Chong J, Hayshi Y, Ikeno R, Arai K, Kitamura M, Koike M, Hirai K, Fukayama M . 1998 J. Virol. 72: 8321–8326

  • Izumi KM, Kieff ED . 1997 Proc. Natl. Acad. Sci. USA 94: 12592–12597

  • Jaffrey SR, Erdjument-Bromage H, Ferris CD, Tempst P, Snyder SH . 2001 Nat. Cell Biol. 3: E46–E49

  • Jenkins DC, Charles IG, Thomsen LL, Moss DW, Holmes LS, Baylis SA, Rhodes P, Westmore K, Emson PC, Moncada S . 1995 Proc. Natl. Acad. Sci. USA 92: 4392–4396

  • Johnson RJ, Stack M, Hazlewood SA, Jones M, Blackmore CG, Hu LF, Rowe M . 1998 J. Virol. 72: 4038–4048

  • Kawanishi M . 1995 Intervirology 38: 206–213

  • Kieff E, Liebowitz D . 1990 Virology Fields BN and Knipe DM (ed.) New York: Raven Press pp 1889–1920

    Google Scholar 

  • Kieser A, Kaiser C, Hammerschmidt W . 1999 EMBO J. 18: 2511–2521

  • Kieser A, Kilger E, Gires O, Ueffing M, Kolch W, Hammerschmidt W . 1997 EMBO J. 16: 6478–6485

  • Klein G, Giovanella BC, Lindahl T, Fialkow PJ, Singh S, Stehlin JS . 1974 Proc. Natl. Acad. Sci. USA 71: 4737–4741

  • Kleinert H, Euchenhofer C, Ihrig-Biedert I, Forstermann U . 1996 J. Biol. Chem. 271: 6039–6044

  • Kulwichit W, Edwards RH, Davenport EM, Baskar JF, Godfery V, Rabb-Traub N . 1998 Proc. Natl. Acad. Sci. USA 95: 11963–11968

  • Kyriakis JM, Banerjee P, Nikolakaki E, Dai T, Rubie EA, Ahmad MF, Avruch J, Woodgett JR . 1994 Nature 369: 156–160

  • Laherty CD, Hu HM, Opipari AW, Wang F, Dixit VM . 1992 J. Biol. Chem. 267: 24157–24160

  • Liebowitz D, Wang D, Kieff E . 1986 J. Virol. 58: 233–237

  • Li SN, Chang YS, Liu ST . 1996 Oncogene 12: 2129–2135

  • Lu JJY, Chen JY, Hsu TY, Yu WCY, Su IJ, Yang CS . 1996 J. Gen. Virol. 77: 1883–1892

  • MacFarlane M, Cohen GM, Dickens M . 2000 Biochem. J. 348: 93–101

  • Mann KP, Staunton D, Thorley-Lawson DA . 1985 J. Virol. 55: 710–720

  • Mannick JB, Asano K, Izumi K, Kieff E, Stamler JS . 1994 Cell 79: 1137–1146

  • Marsden AP, Schappert TK, Michel T . 1992 FEBS Lett. 307: 287–293

  • Martins LM, Earnshaw WC . 1997 Trends Cell Biol. 7: 111–114

  • Massi D, Franchi A, Sardi I, Magnelli L, Paglierani M, Borgognoni L, Maria Reali U, Santucci M . 2001 J. Pathol. 194: 194–200

  • Miller WE, Cheshire JL, Baldwin Jr AS, Raab-Traub N . 1998 Oncogene 16: 1869–1877

  • Moncada S, Palmer RM, Higgs EA . 1991 Pharmacol. Rev. 43: 109–142

  • Mosialos G, Birkenbach M, Yalamanchili R, VanArsdale T, Ware C, Kieff E . 1995 Cell 80: 389–399

  • Mosialos G, Hanissian SH, Jawahar S, Vara L, Kieff E, Chatila TA . 1994 J. Virol. 68: 1697–1705

  • Murono S, Inoue H, Tanabe T, Joab I, Yoshizaki T, Furukawa M, Pagano JS . 2001 Proc. Natl. Acad. Sci. USA 98: 6905–6910

  • Muschel RJ, Soto DE, McKenna WG, Bernhard EJ . 1998 Oncogene 17: 3359–3363

  • Nakagomi H, Dolcetti R, Bejarano MT, Pisa P, Kiessling R, Masucci MG . 1994 Int. J. Cancer 57: 240–244

  • Nathan C . 1992 FASEB J. 6: 3051–3064

  • Nathan C, Xie QW . 1994 Cell 78: 915–918

  • Nicholson DW, Thornberry NA . 1997 Trends Biochem. Sci. 22: 299–306

  • Nilsson BO . 1999 Inflamm. Res. 48: 509–515

  • Pathmanathan R, Prasad U, Sadler R, Flynn K, Raab-Traub N . 1995 N. Engl. J. Med. 333: 693–698

  • Peng M, Lundgren E . 1992 Oncogene 7: 1775–1782

  • Riches DWH, Chan ED, Zahradka EA, Winston BW, Remigio LK, Lake FR . 1998 J. Biol. Chem. 273: 22800–22806

  • Seimiya H, Mashima T, Toho M, Tsuruo T . 1997 J. Biol. Chem. 272: 4631–4636

  • Stamler JS . 1994 Cell 78: 931–936

  • Su IJ, Hsieh HC . 1992 Leukemia Lymphoma 7: 47–53

  • Sylla BS, Hung SC, Davidson DM, Hatzivassiliou E, Malinin NL, Wallach D, Gilmore TD, Kieff E, Mosialos G . 1998 Proc. Natl. Acad. Sci. USA 95: 10106–10111

  • Thomsen LL, Lawton FG, Knowles RG, Beesley JE, Riveros-Moreno V, Moncada S . 1994 Cancer Res. 54: 1352–1354

  • Thomsen LL, Miles DW, Happerfield L, Bobrow LG, Knowles RG, Moncada S . 1995 Br. J. Cancer 72: 41–44

  • Thomsen LL, Scott JM, Topley P, Knowles RG, Keerie AJ, Frend AJ . 1997 Cancer Res. 57: 3300–3304

  • Tang TK, Chang WC, Chan WH, Yang SD, Ni MH, Yu JS . 1998 J. Cell Biochem. 70: 442–454

  • Trivedi P, Hu LF, Chen F, Christensson B, Masucci MG, Klein G, Winberg G . 1994 Eur. J. Cancer 30A: 84–88

  • Valentinis B, Morrione A, Peruzzi F, Prisco M, Reiss K, Baserga R . 1999 Oncogene 18: 1827–1836

  • Verheij M, Bose R, Lin XH, Yao B, Jarvis WD, Grant S, Birrer MJ, Szabo E, Zon LI, Kyriakis JM, Haimovitz-Friedman A, Fuks Z, Kolesnick RN . 1996 Nature 380: 75–79

  • Wang D, Liebowitz D, Kieff E . 1985 Cell 43: 831–840

  • Wang F, Gregory C, Sample C, Rowe M, Liebowitz D, Murray R, Rickinson A, Kieff E . 1990 J. Virol. 64: 2309–2318

  • Wilson KT, Fu S, Ramanujam KS, Meltzer SJ . 1998 Cancer Res. 58: 2929–2934

  • Xie K, Fidler IJ . 1998 Cancer Metastasis Rev. 17: 55–75

  • Yeh TS, Li SN, Wu CJ, Liu ST, Meng CL, Chang YS . 1997 DNA Cell Biol. 16: 1311–1319

  • Yu J-S, Yang S-D . 1994 J. Cell. Biochem. 56: 131–141

Download references

Acknowledgements

This work was supported by grants (NSC89-2318-B-182-005-M51, NSC90-2316-B-182-003) from the National Science Council of Taiwan, a Striving for Excellency grant (89-B-FA04-1-4) from the Ministry of Education, Taiwan and grants (CMRP-724) from Chang Gung University, Tao-Yuan, Taiwan, ROC. PJ Chang is supported by a fellowship from National Health Research Institute grant (NHRI-EX90-8703SL).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jau-Song Yu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yu, JS., Tsai, HC., Wu, CC. et al. Induction of inducible nitric oxide synthase by Epstein-Barr virus B95-8-derived LMP1 in Balb/3T3 cells promotes stress-induced cell death and impairs LMP1-mediated transformation. Oncogene 21, 8047–8061 (2002). https://doi.org/10.1038/sj.onc.1205990

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1205990

Keywords

This article is cited by

Search

Quick links